Suma Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ambernath, Maharashtra, India, established in 1991.
1991 Ambernath, Maharashtra, India Active
Last Updated:
Access Report
About Suma Pharmaceuticals Private Limited

Suma Pharmaceuticals Private Limited, a active private limited company, was established on 06 August 1991 in Ambernath, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U27100MH1991PTC062830. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.45 Cr.

Formerly known as Fast Real Honest Fabricators Private Limited. It upholds a compliant status. Employing 15 professional, Its leadership includes Sumati Ganpat Patil (Director), Ganpat Mahadev Patil (Director). It holds ₹58.58 Cr open charges and ₹26.16 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.126, Chikhloli, Midc New Bhendipada, Ambernath, Maharashtra, 421501.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U27100MH1991PTC062830

  • Registration Number

    062830

  • Incorporation Date

    06 August 1991

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.45 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.45 Cr
  • Company Age 34 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 58.58 Cr
  • Satisfied Charges ₹ 26.16 Cr
  • Revenue Growth **** -31.83%
  • Profit Growth **** -25.71%
  • Ebitda **** 17.19%
  • Net Worth 15.21%
  • Total Assets **** 50.57%
Company report

Suma Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Suma Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Suma Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sumati Ganpat Patil Director 28 Dec 1997 Current
Ganpat Mahadev Patil Director 28 Dec 1997 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Suma Pharmaceuticals.

Suma Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.83% decrease. The company also saw a substantial fall in profitability, with a 25.71% decrease in profit. The company's net worth Soared by an impressive increase of 15.21%.

Suma Pharmaceuticals revenue growth over time
Suma Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -31.83%
*******
*******
*******
*******
Revenue from Operations
*******
 -31.16%
*******
*******
*******
*******
Total Assets
*******
 50.57%
*******
*******
*******
*******
Profit or Loss
*******
 -25.71%
*******
*******
*******
*******
Net Worth
*******
 15.21%
*******
*******
*******
*******
EBITDA
*******
 17.19%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Suma Pharmaceuticals?

In 2023, Suma Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹585,800,000.00

Satisfied Charges

₹261,576,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 58.58 Cr
Latest Charge Details
Date Lender Amount Status
24 May 2023 Bank Of India ₹29.29 Cr Open
15 Mar 2023 Bank Of India ₹29.29 Cr Open
29 Jun 2022 Others ₹2.30 Cr Satisfied
19 Apr 2022 Others ₹1.04 Cr Satisfied
31 Dec 2021 Others ₹1.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Suma Pharmaceuticals?

Suma Pharmaceuticals has a workforce of 15 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Suma Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suma Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Suma Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Suma Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Suma Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Charges

    A charge with Bank Of India amounted to Rs. 29.29 Cr with Charge ID 100731805 was registered on 24 May 2023. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 31 Dec 2021 via Charge ID 100539700 with Others was fully satisfied on 05 May 2023. was documented.

  • Charges

    A charge registered on 30 Sep 2018 via Charge ID 100231323 with Others was fully satisfied on 05 May 2023. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 29 Jun 2022 via Charge ID 100587842 with Others was fully satisfied on 26 Apr 2023. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Suma Pharmaceuticals Private Limited?

The CIN of Suma Pharmaceuticals Private Limited is U27100MH1991PTC062830.

Where is Suma Pharmaceuticals Private Limited headquartered?

Suma Pharmaceuticals Private Limited is headquartered at Plot No.126, Chikhloli, Midc New Bhendipada, Ambernath, Maharashtra, 421501.

When was Suma Pharmaceuticals Private Limited incorporated?

Suma Pharmaceuticals Private Limited was incorporated on 06 August 1991.

Who are the current directors of Suma Pharmaceuticals Private Limited?

The current directors of Suma Pharmaceuticals Private Limited are

What is the primary industry of Suma Pharmaceuticals Private Limited?

The primary industry of Suma Pharmaceuticals Private Limited is Manufacturing.

Is Suma Pharmaceuticals Private Limited a listed company?

Suma Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Suma Pharmaceuticals Private Limited?

The authorized capital of Suma Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.45 Cr.

What is the compliance status of Suma Pharmaceuticals Private Limited?

The compliance status of Suma Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available